- Next Steps: Get Started Prescribing Buprenorphine!
- How to Assess and Treat Patients with Comorbid Health Issues
- How to Conduct Buprenorphine Induction
- How to Establish and Manage a Buprenorphine Practice
- How to Manage Challenging Patients
- How to Comply with Rules, Regulations, and Recordkeeping
- How to Understand Insurance and Billing Issues
- How to Screen for Substance Abuse
- Substance Abuse Screening Guidelines
- Risk Factors for Drug Dependence in Adolescents
- Physical and Psychological Symptoms of Opioid Dependence
- DSM 5 Criteria for Substance Use Disorder
- Recognizing Opioid Withdrawal
- Signs and Symptoms of Polysubstance Abuse
- Medical Comorbidities with Opioid Dependence
- Psychiatric Comorbidities with Opioid Dependence
- Topics to Discuss with Prospective Buprenorphine Patients
- Assessing and Selecting Patients for Buprenorphine Treatment
- How to Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
DSM 5 Criteria for Substance Use Disorder
You should familiarize yourself with the DSM-5 criteria for Substance Use Disorder. They are nearly identical to a combination of the criteria for the diagnoses in the DSM-IV TR of Substance Abuse and Substance Dependence. Specify Opioid Use Disorder, if it is the drug of abuse.
Review printable fact sheets with the DSM-IV criteria:
Note: A new version of the DSM, DSM-5 was released in May 2013, which did away with the separate diagnoses of substance "dependence" and substance "abuse" and replaced them with a single diagnosis, substance "use disorder" based on nearly the same criteria combined. A minimum of 2-3 criteria is required for a mild substance use disorder diagnosis, while 4-5 is moderate, and 6-7 is severe (APA, 2013). The other major change was to remove the criterion related to legal problems and to add one related to substance craving.
The APA's breakdown on changes to substance-related addictive disorder diagnoses introduced by DSM-5. The document goes over substance use disorder, addictive disorders and briefly states the APA's position on caffeine use disorder.